Bangkok, 25 June 2026 – The Securities and Exchange Commission (SEC) has
instructed DOD Biotech Public Company Limited (DOD) to cooperate with its
auditor in reviewing its interim financial statements for
the first quarter of 2026, and to
submit the rectified interim financial statements, which have been reviewed by
the auditor, to the SEC. DOD is also required to make simultaneous public
disclosure through the Stock Exchange of Thailand’s Electronic Listed Company
Information Transmission System (SETLink) by 27 July 2026.